Aithal Ashwini P, Bairy Laxminarayana K, Seetharam Raviraja N, Kumar Naveen
Department of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal Academy of Higher Education, Manipal, Karnataka, India.
Department of Pharmacology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates (UAE).
Stem Cell Investig. 2018 Jul 23;5:21. doi: 10.21037/sci.2018.07.04. eCollection 2018.
To evaluate the haemostatic potential of human bone marrow-derived mesenchymal stromal cells (BM-MSCs) in carbon tetrachloride (CCl) induced liver cirrhosis in Wistar rats.
This was an experimental study. Liver cirrhosis was induced in adult female Wistar rats using CCl. Rats were randomly divided into 6 groups with ten rats in each group: group 1 (normal control group), group 2 (received only CCl), group 3 (CCl + low dose BM-MSCs), group 4 (CCl + high dose BM-MSCs), group 5 (CCl + silymarin), group 6 (CCl + high dose BM-MSCs + silymarin). Thirty days after the treatment, blood samples were collected for liver enzyme level analysis, prothrombin time test and plasma fibrinogen estimations. The rats were then sacrificed, livers were excised and used for histopathological and scanning electron microscopy (SEM) study.
BM-MSCs and the combination treatment of high dose BM-MSCs and silymarin effectively decreased the prothrombin time and increased plasma fibrinogen concentration in rats with CCl induced liver cirrhosis. BM-MSCs treatment produces significant anti-fibrotic effect which was supported by the liver enzyme level analysis, histopathology and SEM study.
Results indicate that treatment of BM-MSCs in combination with silymarin had a better haemostatic effect when compared to the administration of BM-MSCs alone.
评估人骨髓间充质基质细胞(BM-MSCs)对四氯化碳(CCl)诱导的Wistar大鼠肝硬化的止血潜力。
这是一项实验研究。使用CCl诱导成年雌性Wistar大鼠肝硬化。大鼠随机分为6组,每组10只:第1组(正常对照组),第2组(仅接受CCl),第3组(CCl +低剂量BM-MSCs),第4组(CCl +高剂量BM-MSCs),第5组(CCl +水飞蓟宾),第6组(CCl +高剂量BM-MSCs +水飞蓟宾)。治疗30天后,采集血样进行肝酶水平分析、凝血酶原时间测试和血浆纤维蛋白原测定。然后处死大鼠,切除肝脏用于组织病理学和扫描电子显微镜(SEM)研究。
BM-MSCs以及高剂量BM-MSCs与水飞蓟宾的联合治疗有效降低了CCl诱导的肝硬化大鼠的凝血酶原时间,并提高了血浆纤维蛋白原浓度。BM-MSCs治疗产生了显著的抗纤维化作用,这得到了肝酶水平分析、组织病理学和SEM研究的支持。
结果表明,与单独给予BM-MSCs相比,BM-MSCs与水飞蓟宾联合治疗具有更好的止血效果。